BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28502729)

  • 1. Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing.
    Rey JM; Ducros V; Pujol P; Wang Q; Buisine MP; Aissaoui H; Maudelonde T; Olschwang S
    J Mol Diagn; 2017 Jul; 19(4):589-601. PubMed ID: 28502729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
    Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
    Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide CNV analysis in 221 unrelated patients and targeted high-throughput sequencing reveal novel causative candidate genes for colorectal adenomatous polyposis.
    Horpaopan S; Spier I; Zink AM; Altmüller J; Holzapfel S; Laner A; Vogt S; Uhlhaas S; Heilmann S; Stienen D; Pasternack SM; Keppler K; Adam R; Kayser K; Moebus S; Draaken M; Degenhardt F; Engels H; Hofmann A; Nöthen MM; Steinke V; Perez-Bouza A; Herms S; Holinski-Feder E; Fröhlich H; Thiele H; Hoffmann P; Aretz S
    Int J Cancer; 2015 Mar; 136(6):E578-89. PubMed ID: 25219767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.
    Papp J; Kovacs ME; Matrai Z; Orosz E; Kásler M; Børresen-Dale AL; Olah E
    Fam Cancer; 2016 Jan; 15(1):85-97. PubMed ID: 26446593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2.
    Li J; Dai H; Feng Y; Tang J; Chen S; Tian X; Gorman E; Schmitt ES; Hansen TA; Wang J; Plon SE; Zhang VW; Wong LJ
    J Mol Diagn; 2015 Sep; 17(5):545-53. PubMed ID: 26320870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologies.
    Kohda M; Kumamoto K; Eguchi H; Hirata T; Tada Y; Tanakaya K; Akagi K; Takenoshita S; Iwama T; Ishida H; Okazaki Y
    Fam Cancer; 2016 Oct; 15(4):553-62. PubMed ID: 26837502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing.
    Rohlin A; Rambech E; Kvist A; Törngren T; Eiengård F; Lundstam U; Zagoras T; Gebre-Medhin S; Borg Å; Björk J; Nilbert M; Nordling M
    Fam Cancer; 2017 Apr; 16(2):195-203. PubMed ID: 27696107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition.
    Martin-Morales L; Rofes P; Diaz-Rubio E; Llovet P; Lorca V; Bando I; Perez-Segura P; de la Hoya M; Garre P; Garcia-Barberan V; Caldes T
    PLoS One; 2018; 13(9):e0203885. PubMed ID: 30256826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue.
    van Puijenbroek M; Nielsen M; Tops CM; Halfwerk H; Vasen HF; Weiss MM; van Wezel T; Hes FJ; Morreau H
    Clin Cancer Res; 2008 Jan; 14(1):139-42. PubMed ID: 18172263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first mutations in the MYH gene reported in Moroccan colon cancer patients.
    Laarabi FZ; Cherkaoui Jaouad I; Baert-Desurmont S; Ouldim K; Ibrahimi A; Kanouni N; Frebourg T; Sefiani A
    Gene; 2012 Mar; 496(1):55-8. PubMed ID: 22266422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.
    Morak M; Laner A; Bacher U; Keiling C; Holinski-Feder E
    Clin Genet; 2010 Oct; 78(4):353-63. PubMed ID: 20618354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between mutations and mRNA expression of APC and MUTYH genes: new insight into hereditary colorectal polyposis predisposition.
    Aceto GM; Fantini F; De Iure S; Di Nicola M; Palka G; Valanzano R; Di Gregorio P; Stigliano V; Genuardi M; Battista P; Cama A; Curia MC
    J Exp Clin Cancer Res; 2015 Oct; 34():131. PubMed ID: 26511139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic c.34G>T KRAS mutation: a new prescreening test for MUTYH-associated polyposis?
    Aimé A; Coulet F; Lefevre JH; Colas C; Cervera P; Flejou JF; Lascols O; Soubrier F; Parc Y
    Cancer Genet; 2015; 208(7-8):390-5. PubMed ID: 26056087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of genetic alterations in hereditary colorectal cancer screening.
    Pineda M; González S; Lázaro C; Blanco I; Capellá G
    Mutat Res; 2010 Nov; 693(1-2):19-31. PubMed ID: 19931546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex tetra-primer amplification refractory mutation system PCR to detect 6 common germline mutations of the MUTYH gene associated with polyposis and colorectal cancer.
    Piccioli P; Serra M; Gismondi V; Pedemonte S; Loiacono F; Lastraioli S; Bertario L; De Angioletti M; Varesco L; Notaro R
    Clin Chem; 2006 Apr; 52(4):739-43. PubMed ID: 16455870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.
    Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA
    Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
    Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B
    J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome sequencing identifies potential novel candidate genes in patients with unexplained colorectal adenomatous polyposis.
    Spier I; Kerick M; Drichel D; Horpaopan S; Altmüller J; Laner A; Holzapfel S; Peters S; Adam R; Zhao B; Becker T; Lifton RP; Holinski-Feder E; Perner S; Thiele H; Nöthen MM; Hoffmann P; Timmermann B; Schweiger MR; Aretz S
    Fam Cancer; 2016 Apr; 15(2):281-8. PubMed ID: 26780541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas.
    Spier I; Holzapfel S; Altmüller J; Zhao B; Horpaopan S; Vogt S; Chen S; Morak M; Raeder S; Kayser K; Stienen D; Adam R; Nürnberg P; Plotz G; Holinski-Feder E; Lifton RP; Thiele H; Hoffmann P; Steinke V; Aretz S
    Int J Cancer; 2015 Jul; 137(2):320-31. PubMed ID: 25529843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.